{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoMqj84oKDA","lastupdate":"2023-02-10T00:00:00.000Z","update_date":"2023-02-10T00:00:00.000Z","lastModified":"Sep 21, 2024","active":1,"confidence_score":97,"confidence_score_reason":"video or image, markets","urlname":"hallura","minimal_profile":null,"status":"","fullstatus":"","acquired":0,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$Xm5smHfS62RMqlCVoqVqKZksxfDIJL41jS3HzoDOhh2IgiHl31hzJK","name":"Hallura","oneliner":"Hyaluronic Acid Dermal Fillers for Aesthetic Medicine","registrar":"515706810","website":"https://www.hallura.com","careerspage":"","founded_month":8,"founded_year":2017,"formernames":[],"sociallinks":{"twitter":"","youtube":"","facebook":"","linkedin":"https://www.linkedin.com/company/29329136","instagram":""},"social":["https://www.linkedin.com/company/29329136"],"flattenedsociallinks":"https://www.linkedin.com/company/29329136","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":1,"employees":"11-50","employees_exact":22,"patent":1,"raised":7000000,"stage":"A","public_stage":"A","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":["Halura"],"about":"Hallura is building a new technology platform for the creation of the next generation of dermal fillers for aesthetic medicine. \r\n\r\nDesigned to overcome the limitations of current products, Halluras HA Dermal Fillers are answering the growing demand for soft, natural, noninvasive aesthetic treatments. The companys products are based on its proprietary cross-linking technology, which uses a novel cross-linking mechanism to maintain and protect natural HA long chains. \r\n\r\nHallura has completed a full set of in vivo animal studies of its products, demonstrating excellent safety and a higher potential for skin lifting compared with other leading products currently on the market.","climatetech_description":null,"is_climatetech_relevant":null,"phone":"+97248550240","country":null,"address":{"israeli":[{"id":"0328fde2-afdd-41b6-a2a8-28c0ac70ba59","city":"Yokne'am Illit","type":null,"address":"HaCarmel Street 67, Yokne'am Illit, Israel","placeid":null,"notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":null},"headquarter_address":null,"district":"North District","news":[{"id":"QmX5XTgDSchsYcYAShUO2MxfF2CLLad9FM1mHxRwh0iFPptMoBJthi","date":"Nov 10, 2022","link":"https://www.prnewswire.com/news-releases/click-chemistry-concept-inspires-biolinkmatrix-by-hallura-the-next-generation-of-ha-dermal-fillers-301674087.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"aesthetic medical company","company":"Hallura Ltd.","layoffs":null,"summary":"Hallura Ltd., an Israeli aesthetic medical company, has announced the development of its proprietary technology, the BiOLinkMatrix platform, which revolutionizes the way Hyaluronic Acid (HA) is cross-linked in dermal fillers. The technology is inspired by the 2022 Nobel Prize for Click Chemistry, awarded to K. Barry Sharpless, Morten Meldal, and Carolyn R. Bertozzi. Halluras advanced product line includes treatments for skin rejuvenation, fine and deep lines smoothing, and volume restoration in lips and mid-face. The company attributes the exceptional safety and natural outcomes of its products to the use of bio-orthogonal chemistry. Halluras HA dermal fillers aim to provide better, safer fillers with natural and soft aesthetic results.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["Nobel Prize","Click Chemistry","Hyaluronic Acid","Dermal Fillers","BiOLinkMatrix platform"],"date_of_event":"2022-11-10","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"vDrml2doa1QOsmfkPG0wlI4fPQtBtX1dE4QRUhJ1EJuWcvL4Wd47HQ","news_summary":"\"Click Chemistry\" Concept Inspires BiOLinkMatrix by HALLURA™: the Next Generation of HA Dermal Fillers","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"7c5d341a-00df-4106-abf2-4ed80914b413","date":"Mar 2, 2022","link":"https://www.prnewswire.com/news-releases/hallura-announces-successful-topline-results-of-european-multi-site-clinical-trial-with-its-new-biolinkmatrix-ha-aesthetic-dermal-fillers-301493947.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"aesthetic medical","company":"Hallura Ltd.","layoffs":null,"summary":"Hallura Ltd., an Israeli aesthetic medical company, announced successful topline results from its European clinical trial for its next generation Hyaluronic Acid (HA) Dermal Fillers. The trial evaluated the safety and effectiveness of three BiOLinkMatrix gels using different HA concentrations for lips enhancement, nasolabial folds correction, and cheeks enhancement. The study met its primary performance endpoint and demonstrated improvement in aesthetic appearance in all three indications. The treatment effectiveness was sustained in most subjects, and a positive safety profile was shown. The company aims to submit for regulatory approval in key territories after completing the 12-month patient follow-up.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["Hyaluronic Acid Dermal Fillers","BiOLinkMatrix platform","clinical trial","safety and effectiveness","aesthetic appearance"],"date_of_event":"March 2, 2022","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"UIsx2BIrG2qBJm3O0N7NO1Q345OGHzRtfGPdrs32m1lqySROVRbqMD","news_summary":"Hallura Announces Successful Topline Results of European Multi-Site Clinical Trial with its New BiOLinkMatrix HA Aesthetic Dermal Fillers","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"4689f694-720f-44dd-96ef-1d7fd543900f","date":"Jul 1, 2020","link":"https://www.prnewswire.com/il/news-releases/hallura-announces-the-appointment-of-paul-navarre-to-its-board-of-directors-301086716.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"Management Changes","company":"Hallura Ltd.","layoffs":"Not mentioned","summary":"Hallura Ltd., an Israeli aesthetic medical company, has appointed Paul Navarre as an independent director of its Board of Directors. Navarre has over 25 years of experience in the pharmaceuticals and consumer goods industries, having served as CEO of Ferring Holding Inc (US) and President of Allergan International. Hallura, which was founded in 2017, is developing the next generation of Hyaluronic Acid (HA) Dermal Fillers.","partners":"Not mentioned","customers":"Not mentioned","investors":"Alon Medtech Ventures","confidence":9,"key_topics":["Board Appointment","Aesthetic Medical Market"],"date_of_event":"July 1, 2020","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"Not mentioned","structured_issues":["Management Changes"],"acquisition_amount":"Not mentioned","structuredIssuesShow":"#Management Changes","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"ZREvXKeC99iaDjj2o7kFlcf2Gv9ONcSfp0VKC0iVNeyej7XJfXfvWv","news_summary":"Hallura Announces the Appointment of Paul Navarre to Its Board of Directors","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"ef6f286a-fee2-4fc2-8fe6-fd8f3dde492b","date":"Nov 11, 2019","link":"https://en.globes.co.il/en/article-israel-dermal-filler-co-hallura-raises-7m-1001306788","source":"en.globes.co.il","visible":1,"analysis":{"tags":"aesthetic medical, financing round, crosslinking technology","company":"Hallura","layoffs":null,"summary":"Israeli aesthetic medical company Hallura has closed a $7 million Series A financing round led by a group of private investors, including leading plastic surgeons and dermatologists. The company, founded in 2017, has developed a new generation of Hyaluronic Acid (HA) Dermal Fillers using a novel crosslinking technology. The technology aims to meet the growing demand for natural and soft non-invasive aesthetic treatments. Halluras products have shown excellent safety and potential for skin lifting in animal studies. The funding will be used to position the company as a leader in the filler market, which is the largest segment of the global non-invasive aesthetic market.","partners":null,"customers":null,"investors":"group of US, Europe and Israel-based private investors","confidence":8,"key_topics":["Hallura","HA Dermal Fillers","crosslinking technology","aesthetic treatments","plastic surgeons"],"date_of_event":"November 11, 2019","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$7 million","structured_issues":["Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"n9zbVhRoA7lxOzkPMDPj6YshSW9xpjC8axbV5VkC0E7YAyAvLXIjfw","news_summary":"Israel dermal filler co Hallura raises $7m","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":4,"techcommunityinvolvement":null,"mediagallery":[],"tags":["skin-care","anti-aging","cosmetics","dermatology","non-invasive"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz8d0LDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kfr0LkJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Nvx3J0IDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA"],"technologysuccessstory":null,"usecases":[],"businessmodels":["B2C"],"productstage":"Clinical Trial","products":[],"geomarkets":["Europe","North America"],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":2,"lastfunding":"$7M","totalrounds":2,"fundingstage":"A","totalfunding":"$7M","publicinvestors":2,"lastpublicfunding":7000000,"totalpublicrounds":2,"totalpublicfunding":7000000},"team":[{"name":"Paul Navarre","email":"paul@hallura.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4MGO7bMLDA","bounced":true,"claimed":0,"founder":0,"urlname":"paul-navarre","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDg0YjigwgM","position":"Member Board Of Directors - Vice Chairman","last_name":"Navarre","claimtoken":"dfHA78iwoQ82SDoDalu0n3cquaJVb2tRbYDnV9pypuHgYEOcBGYq85","first_name":"Paul","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/panavarre/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2023-02-10 13:14:03.000000","initials":"PN","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Stephane Meunier","email":"stephane@hallura.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoPPOsY0LDA","bounced":false,"claimed":1,"founder":1,"urlname":"stphane-meunier","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICgi5jYqAsM","position":"Co-founder & CEO","last_name":"Meunier","claimtoken":"b1a9cfcc8554e969af92bd4eea10ad7b5761f6feb2ba965e5cc1d60d03a049a5","first_name":"Stephane","picturekey":"$YlwUyL2EY91INuXqyEw7TYRHd7IFcb1Yyx5flD8tFxGgNVINPcoFfA","claimeddate":"2019-06-11","linkedinurl":"https://www.linkedin.com/in/smeunier/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2019-06-11 13:34:15.000000","initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$YlwUyL2EY91INuXqyEw7TYRHd7IFcb1Yyx5flD8tFxGgNVINPcoFfA","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Sveta Shneider","email":"sveta@hallura.com","phone":"","gender":"Female","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4PTIp80JDA","bounced":false,"claimed":0,"founder":0,"urlname":"sveta-shneider","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDg9MHp2QoM","position":"Research & Development Manager","last_name":"Shneider","claimtoken":"6Hv6xttbKNlpVR5OenAL8PS78Nx9BOA0uQjYHvhGmCqOTG82KI9S58","first_name":"Sveta","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/sveta-shneider-1a57424/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2023-02-10 13:13:21.000000","initials":"SS","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":1,"tag_line_edited":1,"sector":"Pharmaceuticals","sectorverify":null,"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoNqyo8cLDA","fullname":"Yotam Maman"},"biverifydate":"2020-02-09T00:00:00.000Z","crunchbaseid":"hallura","lastupdator":"Yanina Wainscheinker","lastupdator_email":"yanina.wainscheinker@sncentral.org","creator":"Jenny Sotnik-Talisman","creator_email":"genys30@yahoo.com","createdate":"2017-12-03T00:00:00.000Z","biverification":"Yotam Maman","sectorverification":null,"affiliatedOrganizations":null,"timeline":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCas7DoCgw","date":"Nov 2019","amount":"$7M","source":"https://en.globes.co.il/en/article-israel-dermal-filler-co-hallura-raises-7m-1001306788","eventtype":"FundingRoundEvent","investment":[{"name":"Undisclosed Investor(s)","type":"Investor","amount":0,"hidden":false,"country":"Europe","fullurl":"/investor_page/undisclosed-investor-s","logokey":null,"tagline":"","urlname":"/investor_page/undisclosed-investor-s","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCE3L3CCgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"2aa319c6-e666-4c2b-a0ef-0c5167dfe1d0","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":7000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODE7LfDCgw","date":"","amount":"Undisclosed","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Alon MedTech Ventures","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/alon-medtech-ventures","logokey":"$rzJjmog4oosBl458a9UDIUGyBACzNAekrZmafTGHNGkzXOnwcJaMpr","tagline":null,"urlname":"/investor_page/alon-medtech-ventures","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgP3fvp8KDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"8509e906-465c-4e88-9547-ee556325b297","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$rzJjmog4oosBl458a9UDIUGyBACzNAekrZmafTGHNGkzXOnwcJaMpr","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"8/2017","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"Hallura","logourl":"https://storage.googleapis.com/clean-finder-353810/$Xm5smHfS62RMqlCVoqVqKZksxfDIJL41jS3HzoDOhh2IgiHl31hzJK","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$Xm5smHfS62RMqlCVoqVqKZksxfDIJL41jS3HzoDOhh2IgiHl31hzJK","seoabout":"Hallura is building a new technology platform for the creation of the next generation of dermal fillers for aesthetic medicine. \r\n\r\nDesigned to overcome th...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":3,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Cosmetic Materials","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kfr0LkJDA","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Biologicals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","classificationName":"coretechnology"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Cosmetics","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Nvx3J0IDA","classificationName":"targetcustomer"},{"depth":2,"name":"Medical Devices Industry","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz8d0LDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"}],"classificationDelimited":["SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Medical Devices Industry#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz8d0LDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA>Cosmetic Materials#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kfr0LkJDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA>Cosmetics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Nvx3J0IDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA"],"classificationsViewModel":"|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA/Cosmetic Materials#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kfr0LkJDA|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA/Cosmetics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Nvx3J0IDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Medical Devices Industry#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz8d0LDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Pharma & Medical Biotechnology","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology","children":[{"title":"Cosmetic Materials","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology>Cosmetic Materials"}]}]}],"targetCustomer":[{"title":"Healthcare & Life Sciences","key":"0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Life Sciences","key":"0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences","children":[{"title":"Cosmetics","key":"0-0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences>Cosmetics"}]},{"title":"Medical Devices Industry","key":"0-0-1","path":"IndustryClassificationModel>Healthcare & Life Sciences>Medical Devices Industry"},{"title":"Healthcare","key":"0-0-2","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare"}]}],"coreTechnology":[{"title":"Biologicals","key":"0-0","path":"TechnologyClassificationModel>Biologicals"}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Cosmetic Materials","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kfr0LkJDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Biologicals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Cosmetics","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Nvx3J0IDA","classificationName":"targetcustomer"},{"depth":2,"name":"Medical Devices Industry","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz8d0LDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Pharma & Medical Biotechnology","Cosmetic Materials"],"coreTechnology":["Biologicals"],"targetCustomer":["Healthcare & Life Sciences","Life Sciences","Cosmetics","Medical Devices Industry","Healthcare"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"inline","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[],"privateequityfunding":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCas7DoCgw","date":"Nov 2019","amount":"$7M","source":"https://en.globes.co.il/en/article-israel-dermal-filler-co-hallura-raises-7m-1001306788","eventtype":"FundingRoundEvent","investment":[{"name":"Undisclosed Investor(s)","type":"Investor","amount":0,"hidden":false,"country":"Europe","fullurl":"/investor_page/undisclosed-investor-s","logokey":null,"tagline":"","urlname":"/investor_page/undisclosed-investor-s","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCE3L3CCgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"2aa319c6-e666-4c2b-a0ef-0c5167dfe1d0","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":7000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODE7LfDCgw","date":"","amount":"Undisclosed","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Alon MedTech Ventures","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/alon-medtech-ventures","logokey":"$rzJjmog4oosBl458a9UDIUGyBACzNAekrZmafTGHNGkzXOnwcJaMpr","tagline":null,"urlname":"/investor_page/alon-medtech-ventures","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgP3fvp8KDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"8509e906-465c-4e88-9547-ee556325b297","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$rzJjmog4oosBl458a9UDIUGyBACzNAekrZmafTGHNGkzXOnwcJaMpr","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"nonequityfunding":[],"merger_acquisitions":[],"others":[]}}